Global Cutting Balloon Catheter Market Anticipated for Progressive CAGR Growth during 2017-2022

Fact.MR

Dublin 2, Ireland, 2018-Feb-09 — /EPR Network/ — Considering the rising prevalence of vascular disorders, medical device equipment manufacturers are focusing on launching more cost-efficient and advanced catheters in the market. This Fact.MR report analyzes the expansion of global cutting balloon catheter market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of Fact.MR’s report is to analyze the global cutting balloon catheter market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global cutting balloon catheter market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to medical devices & surgical instruments.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=145

Highlights of the Report Include: 

1.    Based on raw material, preference for polyurethane based cutting balloon catheter will remain strong during the assessment period.  In terms of revenue, sale of polyurethane based cutting balloon catheters presently account for the largest share of the global market.

2.   Based on indication, use of cutting balloon catheter for treating coronary artery disease will be relatively high. Currently, around 73% revenue share of the global market in generated by use of cutting balloon catheter in coronary artery procedures.

3.   On the basis of end user, sales of cutting balloon catheter will remain highly concentrated in hospitals. In addition, hospitals are the largest end users of cutting balloon catheter. Towards the end of 2017, more than US$ 121 Mn worth cutting balloon catheters will be consumed by hospitals. Currently, revenues from sales of cutting balloon catheters in hospitals command for around 67% share of the global market.

North America to Remain the Largest Market for Cutting Balloon Catheters

Among regions, North America will continue to be the leading market for cutting balloon catheter during the forecast period. This is primarily attributed to the presence of a well-established healthcare sector in the region. Moreover, factors such increasing healthcare awareness and rising healthcare expenditure are supporting the growth of the market in the region. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) is also expected to exhibit a steady growth over the next couple years. Emerging countries such as China and India are anticipated to play a major role in determining the future prospects of the market in the region. Europe is projected to remain another potential market for cutting balloon catheter, which currently command for over 30% share of the global market in terms of revenue.

Browse Full Report with TOC- https://www.factmr.com/report/145/cutting-balloon-catheter-market

North America Spearheading the Global Cutting Balloon Catheter Market

The cutting balloon catheter market in North America is expected to remain attractive in 2017 and beyond. This is owing to existence of an advanced healthcare infrastructure coupled with the rising healthcare spending in countries such as the U.S. and Canada. Meanwhile, Europe is estimated to account for more than 30% revenue share of the market by 2017-end. The market in Asia-Pacific excluding Japan (APEJ) is projected to witness the higher CAGR during the forecast period.

On the basis of indication, the coronary artery disease cutting balloon catheter segment is projected to hold its dominant position over the assessment period. Currently, the segment accounts for close to 73% share of the market in terms of revenue. In addition, the segment is expected to reach a market valuation of over US$ 134 Mn towards the end of 2022.

Based on end user, the hospitals segment will retain its dominance over 2022. The segment is projected to surpass a valuation of US$ 121 Mn by the end of forecast period. The segment currently accounts for nearly 67% revenue share of the global market and is expected to create absolute $ opportunity of US$ 12 Mn from 2017 to 2022.

Competition Tracking

Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic Plc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Cordis Corporation, Cook Medical Inc., MicroPort Scientific Corporation, Cardionovum GmbH, Meril Life Sciences Pvt Ltd, and Hexacath are the leading market players mentioned in the Fact.MR’s report. Majority of these player are concentrating on further production innovation.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=145

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/